Basit öğe kaydını göster

dc.contributor.authorCoskun, Raif
dc.contributor.authorGelincik, Aslı
dc.contributor.authorUnal, Derya
dc.contributor.authorBuyukozturk, Suna
dc.contributor.authorColakoglu, Bahauddin
dc.contributor.authorDemir, SEMRA
dc.contributor.authorOlgac, Muge
dc.date.accessioned2021-03-04T11:09:03Z
dc.date.available2021-03-04T11:09:03Z
dc.date.issued2019
dc.identifier.citationDemir S., Olgac M., Unal D., Coskun R., Gelincik A., Colakoglu B., Buyukozturk S., "Opinions of Turkish Hereditary Angioedema Patients Regarding the Use of C1 Inhibitor Concentrate in the Treatment of Acute Attacks", ASTIM ALLERJI IMMUNOLOJI, cilt.17, sa.1, ss.47-52, 2019
dc.identifier.otherav_70d45865-1023-4fb7-b002-0485f460463e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/77766
dc.identifier.urihttps://doi.org/10.21911/aai.439
dc.description.abstractObjective: No data exists about the perceptions of Turkish hereditary angioedema patients regarding the use of C1 inhibitor concentrate that has been used in the treatment of acute attacks for the last 7 years. Our aim was to evaluate patient opinions about the C1 inhibitor (C1-inh) concentrate and determine the level of satisfaction with this drug.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectALERJİ
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleOpinions of Turkish Hereditary Angioedema Patients Regarding the Use of C1 Inhibitor Concentrate in the Treatment of Acute Attacks
dc.typeMakale
dc.relation.journalASTIM ALLERJI IMMUNOLOJI
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume17
dc.identifier.issue1
dc.identifier.startpage47
dc.identifier.endpage52
dc.contributor.firstauthorID83682


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster